Centese
Omaha
About Centese
Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.5M
- Last round: Series Unknown (Sep 2025)
- Website: centese.com
- Phone: 402-417-0740
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/centese-50581 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.